Toubro S, Astrup A V, Breum L, Quaade F
Research Department of Human Nutrition, Royal Veterinary and Agricultural University, Fredriksberg, Copenhagen, Denmark.
Int J Obes Relat Metab Disord. 1993 Feb;17 Suppl 1:S69-72.
In a randomized, placebo-controlled, double blind study, 180 obese patients were treated by diet (4.2 MJ/day) and either an ephedrine/caffeine combination (20mg/200mg), ephedrine (20mg), caffeine (200mg) or placebo 3 times a day for 24 weeks. 141 patients completed this part of the study. All medication was stopped between week 24-26 in order to catch any withdrawal symptoms. From week 26 to 50, 99 patients completed treatment with the ephedrine/caffeine compound in an open trial design, resulting in a statistically significant (p = 0.02) weight loss of 1.1kg. In another randomized, double-blind, placebo-controlled 8 week study on obese subjects we found the mentioned compound showed lean body mass conserving properties. We conclude that the ephedrine/caffeine combination is effective in improving and maintaining weight loss, further it has lean body mass saving properties. The side effects are minor and transient and no withdrawal symptoms have been found.
在一项随机、安慰剂对照、双盲研究中,180名肥胖患者接受饮食治疗(4.2兆焦耳/天),并每日3次服用麻黄碱/咖啡因组合(20毫克/200毫克)、麻黄碱(20毫克)、咖啡因(200毫克)或安慰剂,为期24周。141名患者完成了该研究的这一部分。在第24至26周期间停用所有药物,以捕捉任何戒断症状。从第26周至50周,99名患者在开放试验设计中完成了麻黄碱/咖啡因化合物的治疗,体重减轻1.1千克,具有统计学意义(p = 0.02)。在另一项针对肥胖受试者的随机、双盲、安慰剂对照8周研究中,我们发现上述化合物具有保留瘦体重的特性。我们得出结论,麻黄碱/咖啡因组合在改善和维持体重减轻方面有效,此外还具有保留瘦体重的特性。副作用轻微且短暂,未发现戒断症状。